The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
GPR40 Is Necessary but Not Sufficient for Fatty Acid Stimulation of Insulin Secretion In Vivo
Open accessAbstract
Long-chain fatty acids amplify insulin secretion from the pancreatic β-cell. The G-protein–coupled receptor GPR40 is specifically expressed in β-cells and is activated by fatty acids; however, its role in acute regulation of insulin secretion in vivo remains unclear. To this aim, we generated GPR40 knockout (KO) mice and examined glucose homeostasis, insulin secretion in response to glucose and Intralipid in vivo, and insulin secretion in vitro after short- and long-term exposure to fatty acids. Our results show that GPR40 KO mice have essentially normal glucose tolerance and insulin secretion in response to glucose. Insulin secretion in response to Intralipid was reduced by ∼50%. In isolated islets, insulin secretion in response to glucose and other secretagogues was unaltered, but fatty acid potentiation of insulin release was markedly reduced. The Gαq/11 inhibitor YM-254890 dose-dependently reduced palmitate potentiation of glucose-induced insulin secretion. Islets from GPR40 KO mice were as sensitive to fatty acid inhibition of insulin secretion upon prolonged exposure as islets from wild-type animals. We conclude that GPR40 contributes approximately half of the full acute insulin secretory response to fatty acids in mice but does not play a role in the mechanisms by which fatty acids chronically impair insulin secretion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Le Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S., Adachi, T., Yamada, M., Sugimoto, Y., Miyazaki, S., & Tsujimoto, G. (2005) · Nature Medicine · doi:10.1038/nm1168 · Cited by 1,545
Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., et al. (2003) · Nature · doi:10.1038/nature01478 · Cited by 1,538
The Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids
Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K., Eilert, M. M., Ellis, C., Elshourbagy, N. A., Goetz, A. S., Minnick, D. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211495200 · Cited by 1,104
Fatty acids, lipotoxicity and insulin secretion
McGarry, J. D., & Dobbins, R. L. (1999) · Diabetologia · doi:10.1007/s001250051130 · Cited by 552
Nilsson, N. E., Kotarsky, K., Owman, C., & Olde, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00488-1 · Cited by 540
Mechanisms and Physiological Significance of the Cholinergic Control of Pancreatic β-Cell Function
Gilon, P., & Henquin, J.-C. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.5.0440 · Cited by 508
Prentki, M., Vischer, S., Glennon, M. C., Regazzi, R., Deeney, J. T., & Corkey, B. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42624-5 · Cited by 442
Steneberg, P., Rubins, N., Bartoov-Shifman, R., Walker, M. D., & Edlund, H. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.03.007 · Cited by 411
Briscoe, C. P., Peat, A. J., McKeown, S. C., Corbett, D. F., Goetz, A. S., Littleton, T. R., McCoy, D. C., Kenakin, T. P., Andrews, J. L., Ammala, C., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706770 · Cited by 400
A Novel Gαq/11-selective Inhibitor
Takasaki, J., Saito, T., Taniguchi, M., Kawasaki, T., Moritani, Y., Hayashi, K., & Kobori, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408846200 · Cited by 396
Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat.
Stein, D. T., Esser, V, Stevenson, B. E., Lane, K. E., Whiteside, J. H., Daniels, M. B., Chen, S., & McGarry, J. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118727 · Cited by 378
Stein, D. T., Stevenson, B. E., Chester, M. W., Basit, M., Daniels, M. B., Turley, S. D., & McGarry, J. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119546 · Cited by 352
A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs
Kotarsky, K., Nilsson, N. E., Flodgren, E., Owman, C., & Olde, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)03064-4 · Cited by 352
Briaud, I., Harmon, J. S., Kelpe, C. L., Segu, V. B. G., & Poitout, V. (2001) · Diabetes · doi:10.2337/diabetes.50.2.315 · Cited by 316
Self-citationFujiwara, K., Maekawa, F., & Yada, T. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00035.2005 · Cited by 253
Role of GPR40 in fatty acid action on the β cell line INS-1E
Shapiro, H., Shachar, S., Sekler, I., Hershfinkel, M., & Walker, M. D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.042 · Cited by 220
Warnotte, C., Gilon, P., Nenquin, M., & Henquin, J.-C. (1994) · Diabetes · doi:10.2337/diab.43.5.703 · Cited by 206
Roduit, R., Nolan, C., Alarcon, C., Moore, P., Barbeau, A., Delghingaro-Augusto, V., Przybykowski, E., Morin, J., Massé, F., Massie, B., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1007 · Cited by 192
Self-citationMechanisms of Compensatory β-Cell Growth in Insulin-Resistant Rats
Jetton, T. L., Lausier, J., LaRock, K., Trotman, W. E., Larmie, B., Habibovic, A., Peshavaria, M., & Leahy, J. L. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2294 · Cited by 171
Self-citationStimulation of insulin secretion by infusion of free fatty acids
Crespin, S. R., Greenough, W. B., & Steinberg, D. (1969) · Journal of Clinical Investigation · doi:10.1172/jci106160 · Cited by 165
Salehi, A., Flodgren, E., Nilsson, N. E., Jimenez-Feltstrom, J., Miyazaki, J., Owman, C., & Olde, B. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-0017-z · Cited by 150
Magnan, C., Collins, S. C., Berthault, M., Kassis, N., Vincent, M., Gilbert, M., Pénicaud, L., Ktorza, A., & Assimacopoulos‐Jeannet, F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3883 · Cited by 115
Effect of plasma free fatty acids on plasma glucagon and serum insulin concentrations
Madison, L. L., Seyffert, W. A., Unger, R. H., & Barker, B. (1968) · Metabolism · doi:10.1016/0026-0495(68)90097-8 · Cited by 115
Inhibition of Insulin Secretion by Leptin in Normal Rodent Islets of Langerhans
Poitout, V., Rouault, C., Guerre-Millo, M., Briaud, I., & Reach, G. (1998) · Endocrinology · doi:10.1210/endo.139.3.5812 · Cited by 108
Self-citationEffects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.
Boden, G., & Chen, X. (1999) · Diabetes · doi:10.2337/diabetes.48.3.577 · Cited by 91
Kotarsky, K., Nilsson, N. E., Olde, B., & Owman, C. (2003) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.2003.pto930601.x · Cited by 64
Alcazar, O., Qiu-yue, Z., Giné, E., & Tamarit‐Rodriguez, J. (1997) · Diabetes · doi:10.2337/diab.46.7.1153 · Cited by 56
Warnotte, C., Gilon, P., Nenquin, M., & Henquin, J. (1994) · Diabetes · doi:10.2337/diabetes.43.5.703 · Cited by 46
Palmitate potentiation of glucose-induced insulin release: a study using 2-bromopalmitate
Parker, S. M., Moore, P. C., Johnson, L. M., & Poitout, V. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00279-8 · Cited by 45
Self-citationLipid partitioning in the pancreatic β cell: physiologic and pathophysiologic implications
Poitout, V. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200204000-00005 · Cited by 17
Self-citation
Cited by
Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
Glucolipotoxicity: fuel excess and β-cell dysfunction
Poitout, V., & Robertson, R. P. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0023 · Cited by 1,092
Self-citationInterplay between lipids and branched-chain amino acids in development of insulin resistance
Newgard, C. B. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.024 · Cited by 1,080
Free Fatty Acid Receptors in Health and Disease
Kimura, I., Ichimura, A., Ohue-Kitano, R., & Igarashi, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00041.2018 · Cited by 1,018
Edfalk, S., Steneberg, P., & Edlund, H. (2008) · Diabetes · doi:10.2337/db08-0307 · Cited by 587
Metadata
- Authors
- Latour, M. G., Alquier, T., Oseid, E., Tremblay, C., Jetton, T. L., Luo, J., Lin, D. C.-H., & Poitout, V.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2007-04-01
- Volume
- 56
- Issue
- 4
- Pages
- 1087-1094
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2115276803
- Cited by
- 259
- References
- 31
- FWCI
- 21.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.